Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA.
J Cardiovasc Transl Res. 2013 Feb;6(1):54-64. doi: 10.1007/s12265-012-9428-x. Epub 2012 Nov 29.
Multiple studies suggest an association between cytomegalovirus (CMV) infection and atherogenesis; however, the molecular mechanisms by which viral infection might exacerbate atherosclerosis are not well understood. Aortas of MCMV-infected and uninfected Apo E knockout (KO) mice were analyzed for atherosclerotic lesion development and differential gene expression. Lesions in the infected mice were larger and showed more advanced disease compared to the uninfected mice. Sixty percent of the genes in the MAPK pathway were upregulated in the infected mice. p38 and ERK 1/2 MAPK genes were 5.6- and 2.0-fold higher, respectively, in aortas of infected vs. uninfected mice. Levels of VCAM-1, ICAM-1, and MCP-1 were ~2.0-2.6-fold higher in aortas of infected vs. uninfected mice. Inhibition of p38 with SB203580 resulted in lower levels of pro-atherogenic molecules and MCMV viral load in aortas of infected mice. MCMV-induced upregulation of p38 may drive the virus-induced acceleration of atherogenesis observed in our model.
多项研究表明巨细胞病毒(CMV)感染与动脉粥样硬化形成之间存在关联;然而,病毒感染加剧动脉粥样硬化的分子机制尚不清楚。分析了感染和未感染载脂蛋白 E 基因敲除(KO)小鼠的巨细胞病毒的胸主动脉粥样硬化病变发展和差异基因表达。与未感染的小鼠相比,感染的小鼠的病变更大,疾病更严重。MAPK 通路中的 60%的基因在感染的小鼠中上调。感染小鼠的 p38 和 ERK1/2MAPK 基因分别比未感染的小鼠高 5.6 倍和 2.0 倍。感染小鼠的 VCAM-1、ICAM-1 和 MCP-1 水平比未感染的小鼠高 2.0-2.6 倍。用 SB203580 抑制 p38 可降低感染小鼠胸主动脉中促动脉粥样硬化分子和巨细胞病毒病毒载量的水平。巨细胞病毒诱导的 p38 上调可能导致我们模型中观察到的病毒诱导的动脉粥样硬化加速。